The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

The distinction between sIBM and the other, mostly hereditary vacuolar myopathies, such as myofibrillar myopathies or hereditary inclusion body myopathy with mutations in the glucosamine (UDP-N ...

Inclusion body myositis (IBM) is an inflammatory myopathy causing proximal and distal muscle weakness. IBM’s cause remains ...

The "Inclusion Body Myositis - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.This report offers in-depth insights into the Inclusion Body Myositis (IBM) pipeline, ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that the ...

Now, the veteran guitarist and singer-songwriter is making medical history as he bravely battles inclusion body myositis. IBM ...

New research examining the skeletal muscle cells of patients with inclusion body myositis (IBM) has revealed that the nucleic acid-binding protein TDP-43, which is normally restricted to the ...

sIBM is a complex disorder, the underlying cause of which is unclear. The observation that the intact muscle fibers are invaded by T lymphocytes, whereas the vacuolated fibers lack T-cell ...